NDA 020516 · Kenvue Brands
Children'S Motrin
Ibuprofen · Oral · Nonsteroidal Anti-inflammatory Drug
Last checked: Nov 20, 2026Latest source record: Jul 22, 2026 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations
First approved
1995
Jun 16, 1995
Approved uses
1
Original approval plus efficacy supplements
Registered trials
910
162 Phase 3, 61 recruiting
FAERS reports
207,153
149,068 serious, 16,562 with death reported
AI brief across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.
What it is approved for
From the label in effect Nov 8, 2024.
Uses temporarily: relieves minor aches and pains due to the common cold, flu, sore throat, headache and toothache reduces fever
Therapeutic areas: Pain and anesthesia
Approval history
Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.
- Jun 16, 1995 Original approval · Type 8 - Partial Rx to OTC Switch
2 products under this application
- CHILDREN'S MOTRIN · IBUPROFEN 100MG/5ML · SUSPENSION, ORAL · Over-the-counter
- MOTRIN IB · IBUPROFEN 200MG/10ML · SUSPENSION, ORAL · Over-the-counter
Clinical trials
Interventional ClinicalTrials.gov studies with "Ibuprofen" as an intervention, any sponsor and status, largest first.
- Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or NaproxenPivotal-lookingCompleted
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.Pfizer (PFE)
NCT00346216 · 24,081 participants · Start Oct 4, 2006 · Primary completion Apr 12, 2016
Drug: celecoxib; Ibuprofen and 1 more · For: Arthritis, Rheumatoid
Sites: Alabaster, Alabama; Bessemer, Alabama; Birmingham, Alabama · 1,066 sites in all
- The Standard Care Versus Celecoxib Outcome TrialPivotal-lookingCompleted
University of DundeeAcademic, hospital or other
NCT00447759 · 7,297 participants · Start Jun 2007 · Primary completion Aug 2015
Drug: Celecoxib; Diclofenac · For: Osteoarthritis; Rheumatoid Arthritis
Sites: Odense, Denmark; Zeist, Netherlands; Aberdeen, United Kingdom · 10 sites in all
- A Clinical Trial to Evaluate the Effectiveness and Safety of Chinese Medicine in the Treatment of Mild Type of Hand, Foot, and Mouth DiseasePivotal-lookingCompleted
The First Affiliated Hospital of Anhui University of Traditional Chinese MedicineAcademic, hospital or other
NCT01182532 · 3,000 participants · Start May 2010 · Primary completion Oct 2011
Drug: TCM Syndrome Differentiation and Treatment · For: Hand, Foot and Mouth Disease
Sites: Hefei, China; Beijing, China; Chongqing, China · 21 sites in all
- Safety of Ibuprofen After Major Orthopaedic SurgeriesPivotal-lookingCompleted
Naestved HospitalAcademic, hospital or other
NCT05575700 · 2,904 participants · Start Apr 17, 2023 · Primary completion Aug 19, 2025
Drug: Ibuprofen; Placebo · For: Pain, Acute; Hip Arthropathy; Knee Arthropathy and 5 more
Sites: Brøndby, Denmark; Copenhagen NV, Denmark; Farsø, Denmark · 11 sites in all
- Use of Ibuprofen to Prevent IUD Site EffectsPivotal-lookingCompleted
FHI 360Academic, hospital or other
NCT00243815 · 2,019 participants · Start Jun 2002
Drug: ibuprofen · For: IUD Removal
Sites: Santiago, Chile
- Opioid Analgesic Reduction StudyPivotal-lookingCompleted
Rutgers, The State University of New JerseyAcademic, hospital or other
NCT04452344 · 1,815 participants · Start Jan 4, 2021 · Primary completion Jul 7, 2023
Drug: opioid-containing analgesic; two over-the-counter analgesics · For: Opioid Use
Sites: Chicago, Illinois; Baltimore, Maryland; Ann Arbor, Michigan · 5 sites in all
- Prehospital Analgesia in Adults Using Inhaled Methoxyflurane StudyPivotal-lookingStatus unknown
Ottawa Hospital Research InstituteAcademic, hospital or other
NCT06392087 · 1,800 participants (planned) · Start Aug 1, 2024 · Primary completion Mar 1, 2025
Drug: Methoxyflurane · For: Pain, Acute
- Perioperative Inflammation and Breast Cancer OutcomePivotal-lookingStatus unknown
Samsung Medical CenterAcademic, hospital or other
NCT02141139 · 1,568 participants (planned) · Start Sep 2014 · Primary completion Jan 2016
Drug: NSAIDS (ketorolac and ibuprofen) · For: Breast Neoplasms
Sites: Seoul, South Korea
Most reported adverse reactions
FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.
- drug ineffective16,396
- pain15,353
- fatigue14,866
- nausea13,934
- headache12,388
- arthralgia11,148
- dyspnoea10,814
- vomiting10,424
- diarrhoea10,065
- rash9,328
- off label use9,255
- dizziness8,413
FAERS reports by year
By the date FDA received the report.
View as table
| Year | Reports |
|---|---|
| 2004 | 1,642 |
| 2005 | 2,167 |
| 2006 | 2,083 |
| 2007 | 2,158 |
| 2008 | 1,815 |
| 2009 | 2,829 |
| 2010 | 4,550 |
| 2011 | 5,826 |
| 2012 | 7,159 |
| 2013 | 6,948 |
| 2014 | 6,643 |
| 2015 | 9,629 |
| 2016 | 13,005 |
| 2017 | 11,791 |
| 2018 | 16,008 |
| 2019 | 17,043 |
| 2020 | 15,766 |
| 2021 | 15,499 |
| 2022 | 14,954 |
| 2023 | 14,097 |
| 2024 | 13,055 |
| 2025 | 13,230 |
| 2026 | 9,247 |
Recalls
0 FDA enforcement reports for this application.
No recalls on record for this application.
Shortages
FDA's drug shortage list.
Not on FDA's shortage list.
Medicare spending
CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.
Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.
Published evidence
PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.
- Short-term Dual Therapy or Mono Therapy With Acetaminophen and Ibuprofen for Fever: A Network Meta-Analysis.
De la Cruz-Mena JE, Veroniki AA, Acosta-Reyes J, et al. · Pediatrics 2024 · Systematic Review, Network Meta-Analysis
- Comparison of Acetaminophen (Paracetamol) With Ibuprofen for Treatment of Fever or Pain in Children Younger Than 2 Years: A Systematic Review and Meta-analysis.
Tan E, Braithwaite I, McKinlay CJD, et al. · JAMA Netw Open 2020 · Meta-Analysis, Research Support, Non-U.S. Gov't
- Paracetamol versus ibuprofen in treating episodic tension-type headache: a systematic review and network meta-analysis.
Alnasser A, Alhumrran H, Alfehaid M, et al. · Sci Rep 2023 · Systematic Review, Network Meta-Analysis
- Trial of Selective Early Treatment of Patent Ductus Arteriosus with Ibuprofen.
Gupta S, Subhedar NV, Bell JL, et al. · N Engl J Med 2024 · Randomized Controlled Trial, Multicenter Study
- Antipyretic effect of oral dipyrone (Metamizole) compared to oral ibuprofen in febrile children: a systematic review and meta-analysis.
Alnajar M, Saker Z, Haji F, et al. · BMC Pediatr 2024 · Comparative Study, Meta-Analysis
- Single dose oral ibuprofen for acute postoperative pain in adults.
Derry C, Derry S, Moore RA, et al. · Cochrane Database Syst Rev 2009 · Meta-Analysis, Systematic Review
Sponsor: Kenvue Brands · Also marketed as Motrin Ib
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.